The electronic quality management system (EQMS) for pharma and medtech market size has grown rapidly in recent years. It will grow from $2.9 billion in 2025 to $3.27 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to growing regulatory scrutiny on quality and compliance processes, increasing adoption of digital quality documentation systems, rising need for standardized CAPA management practices, expanding focus on audit preparedness and inspection readiness, increasing demand for end-to-end quality process visibility.
The electronic quality management system (EQMS) for pharma and medtech market size is expected to see rapid growth in the next few years. It will grow to $5.22 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to growing adoption of cloud-based EQMS platforms across life sciences organizations, increasing investment in predictive quality and risk management capabilities, rising demand for integrated supplier quality management solutions, expanding implementation of automated compliance monitoring frameworks, increasing focus on scalable quality management systems for global operations. Major trends in the forecast period include increasing adoption of centralized quality event management platforms, growing implementation of automated CAPA workflows for compliance management, rising demand for digital document control and version management systems, expanding use of audit management solutions to strengthen regulatory readiness, increasing focus on employee training and qualification tracking across regulated environments.
The rising regulatory inspections and audits are expected to drive the growth of the electronic quality management system (EQMS) for pharma and medtech market in the coming years. Regulatory inspections and audits refer to structured assessments conducted by health authorities to ensure that pharmaceutical and medical technology organizations adhere to established quality and safety standards. The increase in regulatory inspections and audits is driven by more stringent compliance requirements imposed by regulatory bodies to ensure product quality, patient safety, and data integrity. Electronic quality management systems (EQMS) for pharma and medtech support regulatory inspections and audits by centralizing quality documentation, automating compliance workflows, and enabling rapid access to accurate audit records. For instance, in March 2024, according to the twelfth annual survey of the International Forum of Independent Audit Regulators (IFIAR), a Japan-based organization, all five inspection areas showed an increase in the proportion of listed PIE audits inspected that identified at least one finding compared to the 2022 survey. Therefore, the growing regulatory inspections and audits are driving the expansion of the electronic quality management system (EQMS) for pharma and medtech market.
Major companies operating in the electronic quality management system (EQMS) for pharma and medtech market are focusing on developing innovative solutions such as artificial intelligence (AI)-powered quality management platforms to enhance regulatory compliance, automate documentation workflows, and improve operational efficiency in life sciences organizations. Artificial Intelligence (AI)-powered quality management platforms are digital systems that use machine learning and automation to manage quality assurance and compliance processes, helping pharmaceutical and medtech companies reduce manual errors, streamline documentation, improve regulatory compliance, and accelerate decision-making. For instance, in April 2023, Dot Compliance, an Israel-based provider of compliance and quality management software for life sciences, launched the industry’s first AI-based ChatGPT-powered eQMS for life sciences. The platform integrates embedded generative and predictive artificial intelligence with proprietary algorithms to automate quality management tasks, optimize compliance workflows, and improve reporting accuracy. It enables quality assurance professionals to automate document creation, deviation management, and regulatory reporting while enhancing organizational compliance performance. The solution is designed as a ready-to-use cloud-based platform that supports pharmaceutical and medtech companies in accelerating product development timelines and adapting to evolving regulatory requirements.
In April 2024, Clarivate Plc, a UK-based healthcare and information technology company, acquired Global QMS Inc. for an undisclosed amount. With this acquisition, Clarivate Plc aimed to strengthen its Life Sciences & Healthcare segment by integrating cloud-based regulatory reporting and compliance management solutions, thereby expanding its capabilities in manufacturing, supply chain management, and workflow automation for pharmaceutical, medtech, and biotech companies. Global QMS Inc. is a US-based healthcare technology company that specializes in providing quality-management-related solutions and consulting for regulated industries including pharmaceutical and medical device manufacturing.
Major companies operating in the electronic quality management system (eqms) for pharma and medtech market are Oracle Corporation; Siemens AG; Honeywell International Inc.; IQVIA Holdings Inc.; Dassault Systèmes SE; Veeva Systems Inc.; MetricStream Inc.; MasterControl Inc.; ETQ (RPS Inc.); Ideagen plc; PSC Software; Ennov Group; ComplianceQuest Inc.; AmpleLogic Private Limited; AssurX Inc.; Intellect Design Arena Limited; Greenlight Guru LLC; Qualio Technologies Limited; Dot Compliance Ltd.; Scilife NV; QT9 Software Inc.; Omnex Systems LLC; Orcanos Ltd.; ZenQMS LLC; Trackmedium Pty Ltd.; Qualtrax; Pilgrim Quality Solutions.
North America was the largest region in the electronic quality management system (EQMS) for pharma and medtech market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electronic quality management system (EQMS) for pharma and medtech market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electronic quality management system (EQMS) for pharma and medtech market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The electronic quality management system (EQMS) for pharma and medtech market consists of revenues earned by entities by providing services such as software licensing and subscription, cloud-based deployment, system integration with enterprise and manufacturing systems, workflow automation, validation and compliance support, consulting, implementation services, training, technical support, and software maintenance and upgrades. The market value includes the value of related goods and digital tools sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end users are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The electronic quality management system (eqms) for pharma and medtech market research report is one of a series of new reports that provides electronic quality management system (eqms) for pharma and medtech market statistics, including electronic quality management system (eqms) for pharma and medtech industry global market size, regional shares, competitors with a electronic quality management system (eqms) for pharma and medtech market share, detailed electronic quality management system (eqms) for pharma and medtech market segments, market trends and opportunities, and any further data you may need to thrive in the electronic quality management system (eqms) for pharma and medtech industry. This electronic quality management system (eqms) for pharma and medtech market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
The electronic quality management system (EQMS) for pharma and medtech market size is expected to see rapid growth in the next few years. It will grow to $5.22 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to growing adoption of cloud-based EQMS platforms across life sciences organizations, increasing investment in predictive quality and risk management capabilities, rising demand for integrated supplier quality management solutions, expanding implementation of automated compliance monitoring frameworks, increasing focus on scalable quality management systems for global operations. Major trends in the forecast period include increasing adoption of centralized quality event management platforms, growing implementation of automated CAPA workflows for compliance management, rising demand for digital document control and version management systems, expanding use of audit management solutions to strengthen regulatory readiness, increasing focus on employee training and qualification tracking across regulated environments.
The rising regulatory inspections and audits are expected to drive the growth of the electronic quality management system (EQMS) for pharma and medtech market in the coming years. Regulatory inspections and audits refer to structured assessments conducted by health authorities to ensure that pharmaceutical and medical technology organizations adhere to established quality and safety standards. The increase in regulatory inspections and audits is driven by more stringent compliance requirements imposed by regulatory bodies to ensure product quality, patient safety, and data integrity. Electronic quality management systems (EQMS) for pharma and medtech support regulatory inspections and audits by centralizing quality documentation, automating compliance workflows, and enabling rapid access to accurate audit records. For instance, in March 2024, according to the twelfth annual survey of the International Forum of Independent Audit Regulators (IFIAR), a Japan-based organization, all five inspection areas showed an increase in the proportion of listed PIE audits inspected that identified at least one finding compared to the 2022 survey. Therefore, the growing regulatory inspections and audits are driving the expansion of the electronic quality management system (EQMS) for pharma and medtech market.
Major companies operating in the electronic quality management system (EQMS) for pharma and medtech market are focusing on developing innovative solutions such as artificial intelligence (AI)-powered quality management platforms to enhance regulatory compliance, automate documentation workflows, and improve operational efficiency in life sciences organizations. Artificial Intelligence (AI)-powered quality management platforms are digital systems that use machine learning and automation to manage quality assurance and compliance processes, helping pharmaceutical and medtech companies reduce manual errors, streamline documentation, improve regulatory compliance, and accelerate decision-making. For instance, in April 2023, Dot Compliance, an Israel-based provider of compliance and quality management software for life sciences, launched the industry’s first AI-based ChatGPT-powered eQMS for life sciences. The platform integrates embedded generative and predictive artificial intelligence with proprietary algorithms to automate quality management tasks, optimize compliance workflows, and improve reporting accuracy. It enables quality assurance professionals to automate document creation, deviation management, and regulatory reporting while enhancing organizational compliance performance. The solution is designed as a ready-to-use cloud-based platform that supports pharmaceutical and medtech companies in accelerating product development timelines and adapting to evolving regulatory requirements.
In April 2024, Clarivate Plc, a UK-based healthcare and information technology company, acquired Global QMS Inc. for an undisclosed amount. With this acquisition, Clarivate Plc aimed to strengthen its Life Sciences & Healthcare segment by integrating cloud-based regulatory reporting and compliance management solutions, thereby expanding its capabilities in manufacturing, supply chain management, and workflow automation for pharmaceutical, medtech, and biotech companies. Global QMS Inc. is a US-based healthcare technology company that specializes in providing quality-management-related solutions and consulting for regulated industries including pharmaceutical and medical device manufacturing.
Major companies operating in the electronic quality management system (eqms) for pharma and medtech market are Oracle Corporation; Siemens AG; Honeywell International Inc.; IQVIA Holdings Inc.; Dassault Systèmes SE; Veeva Systems Inc.; MetricStream Inc.; MasterControl Inc.; ETQ (RPS Inc.); Ideagen plc; PSC Software; Ennov Group; ComplianceQuest Inc.; AmpleLogic Private Limited; AssurX Inc.; Intellect Design Arena Limited; Greenlight Guru LLC; Qualio Technologies Limited; Dot Compliance Ltd.; Scilife NV; QT9 Software Inc.; Omnex Systems LLC; Orcanos Ltd.; ZenQMS LLC; Trackmedium Pty Ltd.; Qualtrax; Pilgrim Quality Solutions.
North America was the largest region in the electronic quality management system (EQMS) for pharma and medtech market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electronic quality management system (EQMS) for pharma and medtech market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electronic quality management system (EQMS) for pharma and medtech market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The electronic quality management system (EQMS) for pharma and medtech market consists of revenues earned by entities by providing services such as software licensing and subscription, cloud-based deployment, system integration with enterprise and manufacturing systems, workflow automation, validation and compliance support, consulting, implementation services, training, technical support, and software maintenance and upgrades. The market value includes the value of related goods and digital tools sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end users are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The electronic quality management system (eqms) for pharma and medtech market research report is one of a series of new reports that provides electronic quality management system (eqms) for pharma and medtech market statistics, including electronic quality management system (eqms) for pharma and medtech industry global market size, regional shares, competitors with a electronic quality management system (eqms) for pharma and medtech market share, detailed electronic quality management system (eqms) for pharma and medtech market segments, market trends and opportunities, and any further data you may need to thrive in the electronic quality management system (eqms) for pharma and medtech industry. This electronic quality management system (eqms) for pharma and medtech market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Electronic Quality Management System (EQMS) For Pharma And Medtech Market Characteristics
3. Electronic Quality Management System (EQMS) For Pharma And Medtech Market Supply Chain Analysis
4. Global Electronic Quality Management System (EQMS) For Pharma And Medtech Market Trends And Strategies
5. Electronic Quality Management System (EQMS) For Pharma And Medtech Market Analysis Of End Use Industries
7. Global Electronic Quality Management System (EQMS) For Pharma And Medtech Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
8. Global Electronic Quality Management System (EQMS) For Pharma And Medtech Total Addressable Market (TAM) Analysis for the Market
9. Electronic Quality Management System (EQMS) For Pharma And Medtech Market Segmentation
10. Electronic Quality Management System (EQMS) For Pharma And Medtech Market Regional And Country Analysis
11. Asia-Pacific Electronic Quality Management System (EQMS) For Pharma And Medtech Market
12. China Electronic Quality Management System (EQMS) For Pharma And Medtech Market
13. India Electronic Quality Management System (EQMS) For Pharma And Medtech Market
14. Japan Electronic Quality Management System (EQMS) For Pharma And Medtech Market
15. Australia Electronic Quality Management System (EQMS) For Pharma And Medtech Market
16. Indonesia Electronic Quality Management System (EQMS) For Pharma And Medtech Market
17. South Korea Electronic Quality Management System (EQMS) For Pharma And Medtech Market
18. Taiwan Electronic Quality Management System (EQMS) For Pharma And Medtech Market
19. South East Asia Electronic Quality Management System (EQMS) For Pharma And Medtech Market
20. Western Europe Electronic Quality Management System (EQMS) For Pharma And Medtech Market
21. UK Electronic Quality Management System (EQMS) For Pharma And Medtech Market
22. Germany Electronic Quality Management System (EQMS) For Pharma And Medtech Market
23. France Electronic Quality Management System (EQMS) For Pharma And Medtech Market
24. Italy Electronic Quality Management System (EQMS) For Pharma And Medtech Market
25. Spain Electronic Quality Management System (EQMS) For Pharma And Medtech Market
26. Eastern Europe Electronic Quality Management System (EQMS) For Pharma And Medtech Market
27. Russia Electronic Quality Management System (EQMS) For Pharma And Medtech Market
28. North America Electronic Quality Management System (EQMS) For Pharma And Medtech Market
29. USA Electronic Quality Management System (EQMS) For Pharma And Medtech Market
30. Canada Electronic Quality Management System (EQMS) For Pharma And Medtech Market
31. South America Electronic Quality Management System (EQMS) For Pharma And Medtech Market
32. Brazil Electronic Quality Management System (EQMS) For Pharma And Medtech Market
33. Middle East Electronic Quality Management System (EQMS) For Pharma And Medtech Market
34. Africa Electronic Quality Management System (EQMS) For Pharma And Medtech Market
36. Electronic Quality Management System (EQMS) For Pharma And Medtech Market Competitive Landscape And Company Profiles
37. Electronic Quality Management System (EQMS) For Pharma And Medtech Market Other Major And Innovative Companies
41. Electronic Quality Management System (EQMS) For Pharma And Medtech Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Electronic Quality Management System (EQMS) For Pharma And Medtech Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses electronic quality management system (eqms) for pharma and medtech market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for electronic quality management system (eqms) for pharma and medtech? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electronic quality management system (eqms) for pharma and medtech market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Software; Services2) By Deployment Mode: On Premises; Cloud Based
3) By Enterprise Size: Small And Medium Enterprises; Large Enterprises
4) By Application: Document Management; Change Management; Corrective And Preventive Action Management; Training Management; Audit Management; Supplier Quality Management; Other Applications
5) By End User: Pharmaceutical Companies; Biotechnology Companies; Medical Device Manufacturers; Other End Users
Subsegments:
1) By Software: Document Control And Management Software; Corrective And Preventive Action Management Software; Audit Management Software; Training And Compliance Management Software; Risk Management And Analytics Software2) By Services: Implementation And Integration Services; Validation And Compliance Services; Consulting And Advisory Services; Training And Support Services; Maintenance And Upgrade Services
Companies Mentioned: Oracle Corporation; Siemens AG; Honeywell International Inc.; IQVIA Holdings Inc.; Dassault Systèmes SE; Veeva Systems Inc.; MetricStream Inc.; MasterControl Inc.; ETQ (RPS Inc.); Ideagen plc; PSC Software; Ennov Group; ComplianceQuest Inc.; AmpleLogic Private Limited; AssurX Inc.; Intellect Design Arena Limited; Greenlight Guru LLC; Qualio Technologies Limited; Dot Compliance Ltd.; Scilife NV; QT9 Software Inc.; Omnex Systems LLC; Orcanos Ltd.; ZenQMS LLC; Trackmedium Pty Ltd.; Qualtrax; Pilgrim Quality Solutions
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- Oracle Corporation
- Siemens AG
- Honeywell International Inc.
- IQVIA Holdings Inc.
- Dassault Systèmes SE
- Veeva Systems Inc.
- MetricStream Inc.
- MasterControl Inc.
- ETQ (RPS Inc.)
- Ideagen plc
- PSC Software
- Ennov Group
- ComplianceQuest Inc.
- AmpleLogic Private Limited
- AssurX Inc.
- Intellect Design Arena Limited
- Greenlight Guru LLC
- Qualio Technologies Limited
- Dot Compliance Ltd.
- Scilife NV
- QT9 Software Inc.
- Omnex Systems LLC
- Orcanos Ltd.
- ZenQMS LLC
- Trackmedium Pty Ltd.
- Qualtrax
- Pilgrim Quality Solutions
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | August 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.27 Billion |
| Forecasted Market Value ( USD | $ 5.22 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
